CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

Cancer Network
Original article

<![CDATA[COA Warns That Price Negotiation for Medicare Part B Drugs Threatens Community Oncology]]>

RegulatoryNegative
AI Analysis

Summary

The Community Oncology Alliance is warning CMS and Congress that Medicare Part B drug negotiation policies pose a threat to independent cancer practices and patient access.

Importance:3/10
Sentiment:
-0.60
MedicarePrice NegotiationCommunity OncologyPart B DrugsPolicy
Related Companies

Read the original article

Published by Cancer Network on September 21, 2026 5:30 PM

Read Original